An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.

Saved in:
Bibliographic Details
Title: An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.
Authors: Mountzios G; Fourth Department of Medical Oncology and Clinical Trials Unit Henry Dunant Hospital Center, Athens, Greece., Lampaki S; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece., Vozikis A; Laboratory of Health Economics and Management, Department of Economics, University of Piraeus, Piraeus, Greece., Kontogiorgos I; Laboratory of Health Economics and Management, Department of Economics, University of Piraeus, Piraeus, Greece., Papantoniou P; Laboratory of Health Economics and Management, Department of Economics, University of Piraeus, Piraeus, Greece., Koufaki MI; Laboratory of Health Economics and Management, Department of Economics, University of Piraeus, Piraeus, Greece., Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Boutis A; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Christopoulou A; Medical Oncology Unit, S. Andrew Hospital, Patras, Greece., Pastelli N; Department of Pathology, G. Papanicolaou Hospital, Thessaloniki, Greece., Grivas A; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece., Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Lalla E; Third Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Oikonomopoulos G; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Spyratos D; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Rigakos G; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece., Papakotoulas P; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.; Aristotle University of Thessaloniki, Thessaloniki, Greece.; Department of Medical Oncology, German Oncology Center, Limassol, Cyprus., Linardou H; Fourth Oncology Department, Metropolitan Hospital, Athens, Greece.
Source: Lung Cancer (Auckland, N.Z.) [Lung Cancer (Auckl)] 2021 Aug 30; Vol. 12, pp. 93-102. Date of Electronic Publication: 2021 Aug 30 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101632521 Publication Model: eCollection Cited Medium: Print ISSN: 1179-2728 (Print) Linking ISSN: 11792728 NLM ISO Abbreviation: Lung Cancer (Auckl) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2728
DOI:10.2147/LCTT.S318007